Knight Therapeutics Inc.
Equibles does not estimate personal net worth.
Amal Khoury has spoken on 1 earnings call across 1 company, most recently for Knight Therapeutics Inc. on November 5, 2026. Knight Therapeutics Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.
“As Samira mentioned, this quarter we announced the signature and exclusive distribution agreement with Kiowa Kirin International for the commercialization of Boteligil across certain Latin American countries.”
Knight Therapeutics Inc.
Transcript header (unverified)
Knight Therapeutics Inc.
Drug Manufacturers - Specialty & Generic · Healthcare
Knight Therapeutics' Third Quarter 2026 Results Conference Call
Knight Therapeutics Inc.
